0.2 C
New York
Friday, December 2, 2022

Hims & Hers Health Inc. (HIMS): A Case For Going Higher

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Hims & Hers Health Inc. (HIMS) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.07, or -1.25%, to $5.51. Volume reached 28,382 shares, with price reaching a high of $5.74 and a low of $5.51. Recently, Yahoo Finance discussed the stock, revealing that Now More Than Ever Americans Are Open To Exploring Their Sexuality, Hims & Hers’ Nationwide Survey Uncovers The Realities Of Sex In America Today.


Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored

Stocks Info

This NYSE-listed company operates within the Household & Personal Products industry segment, falling under the Consumer Defensive sector. At the end of the last regular session, the stock closed at $5.56 and fluctuated between $5.74 as its day high and $5.51 as its day low. The current market capitalization of Hims & Hers Health Inc. is $1.15B. A total of 1.05 million shares were traded on the day, compared to an average of 1.62M shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, HIMS has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 19,331 shares. Over the last 12 months, there were 47 BUYs and 22 SELLs from insiders. Insiders purchased 6,064,789 shares during that period but sold 6,337,125.

In the most recent transaction, Becklund Irene sold 10,668 shares of HIMS for 5.68 per share on Sep 20. After the transaction, the PAO now owns 6,978 company shares. In a previous transaction on Sep 20, O’Keefe Lynne Chou sold 10,046 shares at 5.68 per share. HIMS shares that Director owns now total 0.

Among the insiders who sold shares, Becklund Irene disposed of 11,002 shares on Sep 09 at a per-share price of $6.64. This resulted in the PAO holding 2,715 shares of HIMS after the transaction. In another insider transaction, Becklund Irene sold 19,331 shares at $5.00 per share on Jul 05. Company shares held by the PAO now total 13,717.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for HIMS in the last 3 months, the mean price target is $7.83 with high estimates of $12.00 and low estimates of $5.00. In terms of 52-week highs and lows, HIMS has a high of $9.19 and a low of $2.72.

As of this writing, HIMS has an earnings estimate of $-0.11 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $-0.1 per share and a lower estimate of $-0.11.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 9 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HIMS is Overweight with a score of 3.29. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 4 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 1 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles

Receive Best Stock To Trade Before The Opening Bell

 

 

100% Free. Stop Anytime. No Spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

292
294

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.